Mogamulizumab-Kpkc Injection
15 interactions 23 cited referencesMogamulizumab-kpkc injection is used to treat mycosis fungoides and Sézary syndrome, two types of cutaneous T-cell lymphoma ([CTCL], a group of cancers of the immune system that first appear as skin rashes), in adults whose disease has not improved, has gotten worse, or has come back after taking other medications. Mog… Read the full Mogamulizumab-Kpkc Injection drug information page →
Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →
Major
Mogamulizumab-Kpkc Injection Adenovirus Vaccine Type 4, Live An increased risk of infection by the live vaccine Details Mogamulizumab-Kpkc Injection Adenovirus Vaccine Type 7, Live An increased risk of infection by the live vaccine Details Mogamulizumab-Kpkc Injection Cholera Vaccine Ipol An increased risk of infection by the live vaccine Details Mogamulizumab-Kpkc Injection Ebola Zaire Vaccine, Live An increased risk of infection by the live vaccine Details Mogamulizumab-Kpkc Injection Influenza Virus Vaccine, Live An increased risk of infection by the live vaccine Details Mogamulizumab-Kpkc Injection Rotavirus Vaccine, Live An increased risk of infection by the live vaccine DetailsNo interactions on this page match that filter — try the next page or clear the filter.
Check another drug
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist